Spiniluma oxyacantha
Spiniluma oxyacantha · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Spiniluma oxyacantha is a botanical species that has recently garnered significant scientific interest due to its potential therapeutic properties. Research has specifically focused on the plant's ability to impact the survival and progression of various malignancies. Investigations into its aqueous fraction have revealed bioactive compounds capable of targeting highly resilient cancer stem cells. By disrupting these cellular drivers, the plant offers a promising avenue for developing new strategies against aggressive tumor growth. Understanding these mechanisms is essential for advancing the role of this species in modern oncology research.
- Synonyms
- Sideroxylon Oxyacanthum · Mastichodendron Oxyacantha
- Common names
- Not available
- Family
- Sapotaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Synonyms
Spiniluma oxyacantha is a botanical species that has been documented under several different scientific names throughout history. Due to shifts in taxonomic classification, it is recognized by the synonym Mastichodendron oxyacantha. Researchers also frequently refer to the plant as Sideroxylon oxyacanthum in various academic texts. These overlapping designations highlight the complex evolutionary relationships and shifting perspectives within plant taxonomy. Understanding these synonymous connections is essential for ensuring accuracy in botanical research and identification.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Spiniluma oxyacantha is a distinctive botanical species belonging to the vast kingdom Plantae. Within this expansive kingdom, the plant is classified under the class Equisetopsida. It further falls into the order Ericales, showcasing its specific evolutionary lineage. As a member of the genus Spiniluma, it possesses unique characteristics that define its biological identity. Finally, it is categorized within the Sapotaceae family, completing its scientific taxonomic profile.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Ericales |
| Family | Sapotaceae |
| Genus | Spiniluma |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Spiniluma oxyacantha exhibits a broad and diverse geographic distribution across multiple continents. Within the African continent, this species is primarily found throughout Northeast Tropical Africa. Specifically, its presence is well-documented in the regions of Eritrea and Ethiopia. The plant also extends its reach into the temperate zones of Asia. This expansion includes significant populations located throughout the Arabian Peninsula, particularly within Saudi Arabia.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Spiniluma oxyacantha grows in a distinct shrub form, creating a dense and structured presence in its natural habitat. This plant is entirely self-supporting, allowing it to maintain its upright posture without the need for external assistance.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Conditions
Spiniluma oxyacantha, also identified as Sideroxylon oxyacanthum, demonstrates significant medicinal potential through its various therapeutic applications. Research indicates that the aqueous fraction of this plant can inhibit cancer stem cells within breast cancer cell lines. In ethnoveterinary practices, the species is highly valued for its effectiveness in treating leech infestations in animals. Furthermore, traditional healers frequently utilize the plant as a primary treatment for various malignancies. These diverse biological activities highlight the plant's importance in both human and veterinary traditional medicine.
Preparations
Spiniluma oxyacantha is prepared as an aqueous fraction derived from its methanolic crude extract. This specific solvent fraction was selected for investigation due to its previously demonstrated cytotoxic effects on breast cancer cell lines. In recent studies, this aqueous preparation was tested for its potential to inhibit cancer stem cells within the JIMT-1 cell line. The results indicated that the fraction produced a dose-dependent reduction in the aldehyde dehydrogenase positive subpopulation of these cells. Furthermore, the application of this fraction significantly reduced cell migration in wound healing assays.